Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

First U.S. MERS-CoV Patient to be Released from Hospital

by Global Biodefense Staff
May 7, 2014
Coronavirus

Colorized transmission electron micrograph of the Middle East respiratory syndrome coronavirus. Credit: NIAID

The man hospitalized in Indiana with the first U.S. case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is improving and could be released from the hospital soon.

Indiana State Department of Health Commissioner William VanNess II, Governor Mike Pence, and CDC and hospital officials updated the media on Monday, saying none of the more than 50 health-care workers and family members who’ve had contact with the patient have tested positive for the virus. MERS-CoV has an incubation period of up to 14 days.

The infected patient had traveled by plane from Riyadh, Saudi Arabia to Chicago, Illinois on April 24, 2014.  He then traveled by bus from Chicago to Indiana. Several days later, he began to experience respiratory symptoms, including shortness of breath, coughing, and fever. He went to the emergency department on April 28th and was admitted on that same day.

Health officials have reportedly contacted a large number of the passengers who traveled on the same flight or bus as the infected patient and none has reported symptoms of the coronavirus.

At least 400 cases of MERS have been reported in the past two years, and more than 100 people have died.

“In this interconnected world we live in, we expected MERS to make its way to the United States,” Dr. Tom Frieden, director of the CDC, said during press conference Friday. “We have been preparing since 2012 for this possibility.”

Tags: CoronavirusEmerging ThreatsMERS-CoV

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Bat Virus Receptor Studies Vital to Predict Spillover Risk
Pathogens

Bat Virus Receptor Studies Vital to Predict Spillover Risk

December 7, 2022
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC